Abcam is a producer and distributor of research-grade antibodies and associated products headquartered in Cambridge, UK, with a US office located in Cambridge, Massachusetts and a Japan office located in Tokyo.  Our products cover research areas such as cancer, cardiovascular, chromatin & nuclear signaling, immunology, neuroscience, and stem cells, and includes a growing range of non-primary antibody products such as secondary antibodies, kits, proteins, peptides and lysates.   Our mission is to build the largest online catalog of the best antibodies in the world.

Akamai has created a digital operating environment for the Web. Our global platform of thousands of specially-equipped servers helps the Internet withstand the crush of daily requests for rich, dynamic, and interactive content, transactions, and applications. When delivering on these requests, Akamai detects and avoids Internet problem spots and vulnerabilities, to ensure Websites perform optimally, media and software download flawlessly, and applications perform reliably. Hundreds of enterprises worldwide use our global platform to sell, inform, entertain, market, advertise, deliver software, and conduct their business online. Through our EdgeControl they also gain insight into worldwide Internet conditions and access to tools to manage their online business. With Akamai's managed services there's no infrastructure to build or deploy. We can have you integrated on our platform in just a few days. Today Akamai handles tens of billions of daily Web interactions for companies like Audi, NBC, and Fujitsu, and organizations like the U.S. Department of Defense and NASDAQ -- powering brand new business models that serve the changing online economy.

Alexandria Real Estate Equities, Inc. (ARE: NYSE), Landlord of Choice to the Life Science Industry®, the largest owner, cluster developer and pre-eminent first-in-class international real estate investment trust focused principally on the ownership, operation, management, redevelopment, selective development and acquisition of properties containing office/laboratory space. Alexandria is the leading provider of real estate to the life science industry, and has an outstanding eleven-year track record as a NYSE listed company with an approximate $6.7 billion total market capitalization (as of September 30, 2008). Alexandria provides high-quality real estate, technical infrastructure, services and capital to the broad and diverse life science sector. Client tenants include institutional (universities and independent not-for-profit institutions), pharmaceutical, biotechnology, medical device, life science product, service, and translational medicine entities, as well as governmental agencies. Alexandria’s international operating platform is based on the principle of “clustering”, with assets and operations strategically located in key life science hub markets.

Ambit Press specializes in digital and offset print, graphic design, marketing and mail house capabilities. Ambit is located in the heart of Kendall Square and proudly serves the neighboring businesses and academics. We offer three core business needs: marketing and communication materials, sophisticated documentation and copying, and corporate identity packages.

The American Red Cross of Massachusetts Bay (ARCMB) operates critical programs and services that improve the lives of women, men and children. ARCMB is one of the largest chapters in the National Red Cross network, providing services across 145 cities and towns in eastern Massachusetts with a combined population of almost four million. The chapter trains and mobilizes nearly 3,500 volunteers who support the delivery of services to over a half million people each year. Headquartered in Cambridge, ARCMB has locations in Boston, Brockton, Fall River, Haverhill, New Bedford, Peabody, Quincy, and Waltham that serve as local sites for community programs, volunteer recruitment, and disaster preparedness and response.

Amgen is a leading human therapeutics company in the biotechnology industry. For more than 25 years, the company has tapped the power of scientific discovery and innovation to advance the practice of medicine. Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry’s first blockbuster medicines. Today, as a Fortune 500 company serving millions of patients, Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness.